GOSSAMER BIO, INC. (GOSS) Net Margin
- 2026-06-30: Net Margin 182.94%.
- 2026-03-31: Net Margin -275.22%.
- 2025-12-31: Net Margin -342.33%.
- 2025-09-30: Net Margin -362.73%.
Complete source-backed net margin history.
- Available history
- 2024-06-30 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|
| 2026-06-30 | 182.94% |
|---|
| 2026-03-31 | -275.22% |
|---|
| 2025-12-31 | -342.33% |
|---|
| 2025-09-30 | -362.73% |
|---|
| 2025-06-30 | -333.13% |
|---|
| 2025-03-31 | -370.49% |
|---|
| 2024-12-31 | -352.16% |
|---|
| 2024-09-30 | -324.93% |
|---|
| 2024-06-30 | 51.37% |
|---|
Annual Net Margin
| Date | Net Margin |
|---|
| 2025-12-31 | -351.49% |
|---|
| 2024-12-31 | -49.28% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | | $6.326B | 25.62 |
|---|